ClinVar Miner

Submissions for variant NM_145868.2(ANXA11):c.118G>T (p.Asp40Tyr)

dbSNP: rs368751524
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000988396 SCV001138099 likely pathogenic Amyotrophic lateral sclerosis type 23 2019-05-28 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002549708 SCV003012444 pathogenic not provided 2022-04-07 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Asp40 amino acid residue in ANXA11. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28469040, 29845112, 33087501). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 802593). This missense change has been observed in individuals with ANXA11-related conditions (PMID: 34048612). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 40 of the ANXA11 protein (p.Asp40Tyr).
3billion, Medical Genetics RCV001836926 SCV003841270 pathogenic Inclusion body myopathy and brain white matter abnormalities 2023-02-23 criteria provided, single submitter clinical testing The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism.Same nucleotide change resulting in same amino acid change has been previously reported to be associated with ANXA11 related disorder (ClinVar ID: VCV000802593). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 34048612 / 3billion dataset). The variant has been reported to co-segregate with the disease in at least 7 similarly affected relatives/individuals in at least two unrelated families (PMID: 34048612). A different missense change at the same codon (p.Asp40Gly) has been reported to be associated with ANXA11 related disorder (ClinVar ID: VCV000488353 / PMID: 28469040). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline.
Baylor Genetics RCV001836926 SCV005049755 pathogenic Inclusion body myopathy and brain white matter abnormalities 2023-12-06 criteria provided, single submitter clinical testing
Baylor Genetics RCV000988396 SCV005049777 pathogenic Amyotrophic lateral sclerosis type 23 2023-12-06 criteria provided, single submitter clinical testing
OMIM RCV001836926 SCV002097624 pathogenic Inclusion body myopathy and brain white matter abnormalities 2022-02-15 no assertion criteria provided literature only
Undiagnosed Diseases Network, NIH RCV001836926 SCV004812021 pathogenic Inclusion body myopathy and brain white matter abnormalities 2024-01-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.